A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients with Multiple System Atrophy
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Teva Branded Pharmaceutical Products R&D, Inc
Start Date
October 17, 2024
End Date
June 30, 2026
Administered By
Neurology, Movement Disorders
Awarded By
Teva Branded Pharmaceutical Products R&D, Inc
Start Date
October 17, 2024
End Date
June 30, 2026